tenk.fyi

Estrella Immunopharma, Inc.

ESLANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$7.3M

34.2% YoY

EPS

$-0.27

99.3% YoY

Cash

$4.2M

68.0% YoY

FY 2024 · As of 2024-06-30